First tests begin on potential new bleeding disorder drug
NCT ID NCT06649630
Summary
This is a first-in-human study to check if a new medicine called Inno8 is safe and how it behaves in the body. It will involve 108 healthy male volunteers who will receive the drug or a placebo via injection or pill. The main goal is to gather safety information to support future testing in people with Haemophilia A, a serious bleeding disorder.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAEMOPHILIA A are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Charité - Campus Charité Mitte - Charité Research Organisation GmbH
RECRUITINGBerlin, 10117, Germany
-
Charité Research Organisation GmbH
NOT_YET_RECRUITINGBerlin, 10117, Germany
Conditions
Explore the condition pages connected to this study.